Targeting Pseudomonas exotoxin to hematologic malignancies

By Kreitman R.J.   Pastan I.  

Seminars in Cancer Biology, Vol. 6, Iss. 5, 1995-10 ,pp. : 297-306

Academic Press

Access to resources Recommend Favorite

Development of the farnesyltransferase inhibitor tipifarnib for therapy of hematologic malignancies

By Karp Judith E   Lancet Jeffrey E  

Future Oncology, Vol. 1, Iss. 6, 2005-12 ,pp. : 719-731

Future Medicine

Access to resources Recommend Favorite

Targeting Sphingosine-1-Phosphate in Hematologic Malignancies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 9, 2011-11 ,pp. : 794-798

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Farnesyltransferase Inhibitors for Clinical Cancer Therapy: Focus on Hematologic Malignancies

By Karp Judith   Lancet Jeffrey  

Cancer Investigation, Vol. 25, Iss. 6, 2007-09 ,pp. : 484-494

Informa Healthcare

Access to resources Recommend Favorite

The Evolution of Clonality Testing – Next Generation Sequencing in the Diagnosis and Monitoring of Hematologic Malignancies

By Gazzola Anna   Mannu Claudia   Rossi Maura   Laginestra Maria Antonella   Sapienza Maria Rosaria   Fuligni Fabio   Etebari Maryam   Melle Federica   Sabattini Elena   Agostinelli Claudio   Bacci Francesco   Sacchetti Carlo Alberto Sagramoso   Pileri Stefano Aldo   Piccaluga Pier Paolo  

The Journal of OncoPathology, Vol. 2, Iss. 2, 2014-06 ,pp. : 19-24

Optimal Clinical Ltd

Access to resources Recommend Favorite